Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 78 record(s)

Req # A-2020-001603

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03331704.

Organization: Health Canada

10 page(s)
April 2021

Req # A-2020-001677

Adverse Drug Reaction (ADR) for METRONIDAZOLE. Report number: E2B_01198405.

Organization: Health Canada

64 page(s)
April 2021

Req # A-2020-001763

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03473172.

Organization: Health Canada

15 page(s)
April 2021

Req # A-2021-000013

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_00476395.

Organization: Health Canada

15 page(s)
April 2021

Req # A-2019-001646

Adverse Reaction Report (AER) for HYDROCHLOROTHIAZIDE, IRBESARTAN. Report number: E2B_02372540.

Organization: Health Canada

7 page(s)
April 2020

Req # A-2019-001653

Adverse Reaction Report (AER) for PSEUDOEPHEDRINE HYDROCHLORIDE. Report number: E2B_02601741.

Organization: Health Canada

11 page(s)
April 2020

Req # A-2019-001858

All records which went into the decision to implement of sex/gender tracking for medical device incidents which began in February 2020.

Organization: Health Canada

20 page(s)
April 2020

Req # A-2019-001595

Adverse Reaction Report (AER) for DEXLANSOPRAZOLE. Report number: E2B_02752874.

Organization: Health Canada

42 page(s)
April 2020

Req # A-2019-001599

Adverse Reaction Report (AER) for ONDANSETRON. Report numbers: 000729490, E2B_02743135.

Organization: Health Canada

15 page(s)
April 2020

Req # A-2019-001635

Adverse Reaction Report (AER). Report number: E2B_02648588.

Organization: Health Canada

18 page(s)
April 2020
Date modified: